Scientific paper - Original scientific paper
Remdesivir use in severe and critical COVID-19 patients might be associated with lower incidence of arterial thrombotic events
The American Journal of Emergency Medicine, 70 (2023); 41-45. https://doi.org/10.1016/j.ajem.2023.05.007

Lucijanić, Marko; Bistrović, Petra; Jordan, Ana; Mihaljević, Iva; Bukvić, Stela; Kovačević, Stjepan; Ranilović, Darjan; Sakota, Sara; Vlasac Glasnović, Josipa; Delić-Brkljačić, Diana

Cite this document

Lucijanić, M., Bistrović, P., Jordan, A., Mihaljević, I., Bukvić, S., Kovačević, S. ... Delić Brkljačić, D. (2023). Remdesivir use in severe and critical COVID-19 patients might be associated with lower incidence of arterial thrombotic events. The American Journal of Emergency Medicine, 70., 41-45. doi: 10.1016/j.ajem.2023.05.007

Lucijanić, Marko, et al. "Remdesivir use in severe and critical COVID-19 patients might be associated with lower incidence of arterial thrombotic events." The American Journal of Emergency Medicine, vol. 70, 2023, pp. 41-45. https://doi.org/10.1016/j.ajem.2023.05.007

Lucijanić, Marko, Petra Bistrović, Ana Jordan, Iva Mihaljević, Stela Bukvić, Stjepan Kovačević, Darjan Ranilović, Sara Sakota, Josipa Vlasac Glasnović and Diana Delić Brkljačić. "Remdesivir use in severe and critical COVID-19 patients might be associated with lower incidence of arterial thrombotic events." The American Journal of Emergency Medicine 70 (2023): 41-45. https://doi.org/10.1016/j.ajem.2023.05.007

Lucijanić, M., et al. (2023) 'Remdesivir use in severe and critical COVID-19 patients might be associated with lower incidence of arterial thrombotic events', The American Journal of Emergency Medicine, 70, pp. 41-45. doi: 10.1016/j.ajem.2023.05.007

Lucijanić M, Bistrović P, Jordan A, Mihaljević I, Bukvić S, Kovačević S, and sur.. Remdesivir use in severe and critical COVID-19 patients might be associated with lower incidence of arterial thrombotic events. The American Journal of Emergency Medicine [Internet]. 2023 August [cited 2024 February 29];70:41-45. doi: 10.1016/j.ajem.2023.05.007

M. Lucijanić, et al., "Remdesivir use in severe and critical COVID-19 patients might be associated with lower incidence of arterial thrombotic events", The American Journal of Emergency Medicine, vol. 70, pp. 41-45, August 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:923043. [Accessed: 29 February 2024]

Please login to the repository to save this object to your list.